A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00773240
Recruitment Status : Completed
First Posted : October 16, 2008
Last Update Posted : August 30, 2011
Information provided by (Responsible Party):
ALK-Abelló A/S